Thursday’s analyst calls: CVS gets upgraded, JPMorgan lowers rating on industrial giant

[ad_1] (This is CNBC Pro’s live coverage of Thursday’s analyst calls and Wall Street chatter. Please refresh every 20-30 minutes to view the latest posts.) A pharmacy operator and an industrial stock were among the stocks being talked by analysts on Thursday. Barclays upgraded CVS to overweight from equal weight, calling for 24% upside. Meanwhile,…

Read More

Ether has been dramatically underperforming bitcoin as the investment case for the cryptocurrency weakens

[ad_1] Crypto investors are starting to question the investment opportunity in ether . Ethereum has always been seen as the blockchain with a stronger and more easily understood value proposition as a smart contracts platform that could power many different types of applications. Now, investors are reckoning with the possibility that ether may have lost…

Read More

Thursday’s analyst calls: Nucor, Dutch Bros get positive views despite slides in shares

[ad_1] (This is CNBC Pro’s live coverage of Thursday’s analyst calls and Wall Street chatter. Please refresh every 20-30 minutes to view the latest posts.) Steelmaker Nucor and drive-through beverage company Dutch Bros were in focus for analysts Thursday who see room for growth in both stocks. Rising steel prices should benefit Nucor, while Dutch…

Read More

The ‘Trump trade’ has divided health-care stocks into two camps. How to play the next moves

[ad_1] This year’s presidential election is already sending health-care stocks on a wild ride. Historically, shifts in political control have created “increased volatility” across the health care sector, sending investors “to look for areas of safety,” Raymond James analyst Chris Meekins said in a July 7 note. “This election is likely to produce distinct, binary,…

Read More

GameStop shares surge 73% in premarket after ‘Roaring Kitty’ trader posts account showing $116 million position

[ad_1] Meme stock GameStop rallied again in premarket trading Monday on speculation Keith Gill, the man who inspired 2021’s epic short squeeze, could have a huge position in the video game retailer. Shares in premarket trading were 73% higher at 5:10 a.m. ET, after soaring 90% earlier in the morning. It comes after the stock…

Read More

Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch

[ad_1] Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin treating patients, some investors see better times ahead next year. “We’ve seen a lot of innovation,” Dan Lyons, portfolio manager on the health-care team at Janus Henderson, said, explaining that he is bullish on 2024…

Read More

Oprah’s flip on weight loss drugs is a sign of what’s to come for the ‘Ozempic trade’ in 2024

[ad_1] For many struggling with obesity, new medications have been “a gift,” as Oprah Winfrey recently described it in declaring she was “done with the shaming.” Investors in drug manufacturers Novo Nordisk and Eli Lilly might use the same term for the returns they’ve realized over the past year. U.S.-listed shares of Novo Nordisk, the…

Read More